Qiagen NV | QIA - Market Capitalization

Stock Price
43.48
Daily Change
-0.26 -0.58%
Monthly
3.29%
Yearly
7.21%
Q1 Forecast
43.53

Qiagen NV reported $9.28B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 2M Sep/2025
argenx SE USD 44.32B 15.63B Sep/2025
Avita Medical AUD 140.79M 194.8M Jun/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
IQVIA Holdings USD 33.26B 5.13B Feb/2026
Moderna USD 10.09B 581M Sep/2025
Organon & Co USD 2.18B 593.28M Feb/2026
Qiagen NV USD 9.6B 89.01M Feb/2026
Revvity USD 13.23B 3.47B Feb/2026
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 11.54B 1.06B Sep/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026